CJC/Ipamorelin 5mg

This formulation offers a comprehensive solution for anyone looking to optimize their growth hormone levels safely and effectively.

Price :

$60.00

Out of stock

Researched Benefits

Promotes growth hormone release, improves recovery, and supports fat loss.
Disclaimer

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE. ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

References to human benefits are based on theoretical extrapolation from laboratory findings and should not be construed as medical claims or therapeutic recommendations. Research should be conducted only by licensed researchers in appropriate laboratory settings.

These products are not intended to be used as foods, drugs or cosmetics, any sort of bodily introduction of the products into humans or animals is strictly prohibited. They must also not be misbranded misused, or mislabeled, or used for anything other than research and scientific investigation.

All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.

The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.

The products we are selling come in a sealed vial but require additional lab equipment for proper testing. This equipment includes bacteriostatic water (for reconstitution), syringes and needles (to draw the product from the vial/apply bacteriostatic water), alcohol disinfection pads etc.

Though we make sure packaging, label, seals and writing does not differ from the product photos you see on our website, there is a chance for a minimal deviation.

The CJC-1295/Ipamorelin complex represents a sophisticated approach to growth hormone secretagogue research, combining a growth hormone-releasing hormone (GHRH) analog with a selective ghrelin receptor agonist. This dual-mechanism preparation demonstrates enhanced stability and receptor specificity compared to singular peptide interventions, warranting particular attention in molecular endocrinology research.

CJC-1295

  • Modified GHRH analog with Drug Affinity Complex (DAC)
  • Strategic lysine modifications enhancing plasma protein binding
  • Terminal modifications for enhanced enzymatic stability
  • Optimized amino acid sequence for receptor interaction

Ipamorelin

  • Pentapeptide ghrelin receptor agonist
  • Selective binding domain architecture
  • Modified C-terminus for enhanced stability
  • Optimized conformational structure

Neuroendocrine Modulation

Laboratory investigations reveal sophisticated mechanisms:

  • Enhanced somatotroph cell activation
  • Pulsatile growth hormone release patterns
  • Hypothalamic-pituitary axis regulation
  • Selective receptor-mediated responses

Cellular Signaling Cascades

Research models demonstrate multiple pathway activations:

  • GHRH receptor-mediated cAMP elevation
  • GHS-R1a receptor signal transduction
  • Protein kinase A pathway modulation
  • Calcium channel dynamics

Synergistic Effects

In vitro studies identify enhanced outcomes through combined administration:

  • Amplified growth hormone pulse amplitude
  • Extended secretory response duration
  • Optimized receptor sensitivity patterns
  • Enhanced cellular response persistence

Metabolic Implications

Laboratory findings indicate complex metabolic modulation:

  • Enhanced protein synthesis pathways
  • Lipolytic cascade activation
  • Glucose homeostasis regulation
  • Cellular energy utilization patterns

Tissue-Specific Responses

Research reveals differential tissue effects:

  • Enhanced muscle protein synthesis
  • Adipose tissue metabolism modulation
  • Bone matrix protein regulation
  • Connective tissue adaptation patterns